---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-023200"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2022-02-14T23:59:59+00:00"
generated_at: "2026-06-27T08:20:27.873630+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kiora Pharmaceuticals CFO Sarah Romano resigns effective Feb 25, 2022

## Summary
- CFO Sarah Romano will resign effective Feb 25, 2022 to pursue another opportunity.
- Resignation not due to any disagreement with the Company's operations, policies or practices.
- No successor has been announced as of the filing date.

## SEC filing metadata
- accession: 0001104659-22-023200
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2022-02-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000110465922023200/0001104659-22-023200-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000110465922023200/tm226703d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-023200
- JSON: https://secwatch.observer/filing/0001104659-22-023200.json
- Plain text: https://secwatch.observer/filing/0001104659-22-023200.txt

## Key facts
- Executive change
  Sarah Romano resigned as Chief Financial Officer at KIORA PHARMACEUTICALS INC.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On February 9, 2022, Sarah Romano, the Chief Financial Officer of Kiora Pharmaceuticals, Inc. (the “Company”), notified the Company that she will resign as Chief Financial Officer effective as of February 25, 2022 (the “Effective Date”) to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922023200/0001104659-22-023200-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.